Lab automation and smart reagent supply chain market seen reaching $2.6B by 2030

The Business Research Company says the laboratory automation and smart reagent supply chain market will grow from $1.52 billion in 2025 to $2.6 billion by 2030, driven by personalized medicine, AI, robotics and real-time inventory tools. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Laboratories are under pressure to do more work with fewer errors and tighter inventory control. - The market outlook points to stronger demand for automation that can speed sample processing, improve traceability and reduce reagent waste. - Personalized medicine is adding urgency because it requires high-throughput, precise and reproducible testing.

What happened: - The Business Research Company published a report on the laboratory automation and smart reagent supply chain market on July 2, 2026. - The report values the market at $1.52 billion in 2025 and projects $1.69 billion in 2026. - The market is forecast to reach $2.6 billion by 2030. - The report estimates a 11.2% compound annual growth rate from 2025 to 2026 and a 11.5% CAGR through 2030. - North America led the market in 2025. - Asia-Pacific is projected to grow the fastest during the forecast period.

The details: - Manual laboratory procedures, high-throughput drug discovery, pharma and biotech research, sample tracking needs and clinical diagnostic lab expansion supported historical growth. - Fully automated laboratory ecosystems are expected to drive the next phase of expansion. - Real-time reagent inventory monitoring is becoming a key buying priority. - AI-supported decision-making is spreading across laboratory operations. - Robotics and connectivity improvements are broadening automation capabilities. - Emerging trends include AI-driven workflow optimization, robotic sample preparation, IoT-enabled reagent tracking, cloud-based laboratory information management systems and predictive analytics for inventory management. - The report defines laboratory automation and smart reagent supply chains as integrated systems that use robotics, artificial intelligence and IoT tracking for monitoring, sample processing, inventory control and data-backed decisions. - The report says these systems improve laboratory efficiency, accuracy and operational performance. - The report also says personalized medicine is a major growth driver because genomic, proteomic and metabolic data are increasingly shaping testing and treatment. - Laboratory automation supports personalized medicine by enabling faster, more precise processing and better reagent management. - In February 2024, the Personalized Medicine Coalition said personalized medicines accounted for over one-third of new FDA drug approvals in 2023, up from 28% in 2022. - That was the fourth straight year of growth in the category. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables. - More information is available in the full report. - A free sample of the report is also available.

Between the lines: - The forecast suggests lab suppliers are shifting from standalone automation tools toward connected systems that combine instruments, software and inventory management. - The emphasis on AI, IoT and cloud software signals a market moving toward real-time operational control rather than simple equipment upgrades. - Personalized medicine is not just a clinical trend. It is becoming a procurement and workflow driver for laboratory infrastructure.

What's next: - The fastest growth should come from labs that adopt integrated automation, reagent monitoring and data-driven workflow management. - The report points to continued expansion in robotic sample prep, predictive inventory tools and cloud-connected lab systems through 2030. - Asia-Pacific is expected to narrow the gap with North America as adoption accelerates across the forecast period.

The bottom line: - Laboratory automation and smart reagent supply chains are moving from efficiency upgrades to core lab infrastructure, with the market on track to nearly double by 2030.